Alias
科研级 Lintuzumab ( 林妥珠单抗 ), Anti-CD33 Recombinant Antibody, Research Grade Lintuzumab
Molecular Name
Lintuzumab
Applications
IF, IP, Neut, FuncS, ELISA, FC, ICC
Purity
≥95% as determined by SDS-PAGE
Buffer
Supplied in PBS, PH7.5
Target
CD33[Homo sapiens]
Sequence
Please contact our sales representative to learn more information about this reagents.
Background
Lintuzumab (SGN-33) is a humanized monoclonal antibody used in the treatment of cancer. The drug had been developed by Seattle Genetics as a treatment for acute myeloid leukemia (AML), a condition which results in the deaths of 9, 000 people a year in the United States.
Storage
该产品可在 2°C-8°C 下保存一个月,活性不会明显降低。在 -20°C 至 -80°C 下保存,可稳定保存十二个月。避免反复冻融,用冰袋运输。